Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
暂无分享,去创建一个
G. Camussi | G. Migliardi | S. Ferrari | P. Picci | M. Alberghini | L. Gammaitoni | M. Aglietta | F. Bussolino | G. Grignani | F. Fagioli | S. Bruno | M. Motta | B. Torchio | G. Cavalloni | Y. Pignochino | A. Bottos | Marta Tapparo | Giorgia Migliardi